Inventor · name-matched record
CHEN XICHAO
1 granted patent·4 pending applications·0 citations·filing 2023–2025
12Inventor score
Files withBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD2BEIJING TIDE PHARMACEUTICAL CO LTD1BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD1HANGZHOU TIANLONG PHARMACEUTICAL CO LTD1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
5 records- 0175US2026008769A1Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0263US12545637B2Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity and its compositionBEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Granted Feb 10, 2026·0 cites·24 claims
- 0357US2026007613A1Long-acting low-toxicity novel cationic lipid compounds and composition thereofBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0455US2026007601A1Ionizable cationic lipid compound and composition for delivering nucleic acid and use thereofBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0553US2026008746A1Cationic lipid compound with high efficiency, low toxicity and stable expression, and composition comprisng sameHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHEN XICHAO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →